Jonathan Richman is a respected e-marketer and the author of Dose of Digital blog, in which he writes there is a Myth of Adverse Event Reporting in pharma marketing.  Drawing upon a Nielsen Study which found that only 1 in 500 postings on the Yahoo Health discussion boards met the full criteria for adverse event reporting, pharma may in fact be over-sensitized to the issue. Do AER staffing requirements prevent social media dialogue? Read more »

As if mastering the obscure art of ethical Search Engine Optimization (SEO) wasn’t difficult enough along comes a term to make it more confusing: SEO 2.0.   An ill-defined and conveniently vague term that can mean almost anything, including: Converting visitors to prospects who take action such as filling out a form, downloading a white paper, watching a video, or placing an order. Optimizing your site for social media and link sharing with services like StumbleUpon, Digg and Facebook. Read more »

In pharmaceutical marketing they’re known as “Key Opinion Leaders.”  In medical device sales they’re “super surgeons.” And In social media networks, they’re the people with they greatest number of friends. Uncovering these individuals is the easy party. Read more »